AmbioPharm - A Global Peptide CDMO
AmbioPharm is a global peptide CDMO founded in 2005, specializing in developing efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at various scales. They offer custom peptide synthesis, GMP manufacturing, vaccine services, and cosmetic peptide manufacturing. AmbioPharm's facilities in the US and China are FDA-inspected and capable of handling projects from milligrams to metric tons, providing high-quality peptides at competitive prices with fast delivery. Their expertise includes solid-phase and solution peptide chemistry, organic synthesis, and conjugations to proteins, offering research-grade peptides for pre-clinical programs.
AmbioPharm - A Global Peptide CDMO
AmbioPharm is a global peptide CDMO founded in 2005, specializing in developing efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at various scales. They offer custom peptide synthesis, GMP manufacturing, vaccine services, and cosmetic peptide manufacturing. AmbioPharm's facilities in the US and China are FDA-inspected and capable of handling projects from milligrams to metric tons, providing high-quality peptides at competitive prices with fast delivery. Their expertise includes solid-phase and solution peptide chemistry, organic synthesis, and conjugations to proteins, offering research-grade peptides for pre-clinical programs.
ambiopharm.com
1024 Dittman Court North Augusta, SC 29842, US
Details
Year founded
2005
Revenue
75M-200M
Employees
501-1000
Number of locations
2
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- Biologically Active Peptides
- Custom Organic Synthesis
- Custom Peptide Synthesis
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- CEM Liberty Pro Microwave Peptide Synthesizer
- CEM Liberty Blue Microwave Peptide Synthesizer
- Preparative HPLC columns
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that ambiopharm a global peptide cdmo is ramping up production.
Target industries
Employees working in AmbioPharm - A Global Peptide CDMO
Employees working in AmbioPharm - A Global Peptide CDMO
Locations (2)
AmbioPharm - A Global Peptide CDMO
1024 Dittman Court North Augusta, SC 29842, US
AmbioPharm - A Global Peptide CDMO
No.399, Yingong Road, Fengxian Sub-zone Shanghai Chemical Industry Park Shanghai, CN
People Also Searched For
Frequently Asked Questions
What services & capabilities does AmbioPharm - A Global Peptide CDMO offer?
AmbioPharm - A Global Peptide CDMO offers a range of services and capabilities, including Biologically Active Peptides.
What kind of equipment does AmbioPharm - A Global Peptide CDMO use?
AmbioPharm - A Global Peptide CDMO uses a variety of equipment, including CEM Liberty Pro Microwave Peptide Synthesizer.
What are the target industries of AmbioPharm - A Global Peptide CDMO?
AmbioPharm - A Global Peptide CDMO serves several industries, including the medical industry.
How many locations does AmbioPharm - A Global Peptide CDMO operate?
AmbioPharm - A Global Peptide CDMO operates from 2 locations.
Where are the headquarters of AmbioPharm - A Global Peptide CDMO?
The headquarters of AmbioPharm - A Global Peptide CDMO are located in 1024 dittman court, north augusta, south carolina 29842, united states.
What is the NAICS code for AmbioPharm - A Global Peptide CDMO?
The NAICS code for AmbioPharm - A Global Peptide CDMO is 3254.
How many employees does AmbioPharm - A Global Peptide CDMO have?
AmbioPharm - A Global Peptide CDMO has 529 employees.
What is the official website of AmbioPharm - A Global Peptide CDMO?
The official website of AmbioPharm - A Global Peptide CDMO is https://www.ambiopharm.com/.
When was AmbioPharm - A Global Peptide CDMO founded?
AmbioPharm - A Global Peptide CDMO was founded in 2005.